MarginsXMarginsX
Home › Markets › Health Care › NKTR

Nektar Therapeutics (NKTR)

NKTR trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$36.44
-2.23% on the day
Market cap
$1.2B
Small cap
Revenue · 2025
$55.2M
-43.9% on 2024
Net income · 2025
-$164.1M
-297.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/906709/000119312526104547/0001193125-26-104547-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerNKTR on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000906709
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$55.2M
Net income-$164.1M
Operating income-$140.1M
Net margin-297.1%
Operating margin-253.7%
Revenue growth-43.9%
Cash$15.1M
Total assets$280.4M
P/E (computed)Net income was not positive
P/S (computed)22.6×

Warning signs

Cash runway
1.6 months
$34.7M cash at September 30, 2026
Share count, 1 year
+68.2%
2025-10-31 to 2026-11-06 · +169.0% over 3 years
Going-concern doubt
No
10-Q filed November 13, 2026
Insider net buying, 12 months
-$2.4M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-13
Cash and burn$34.7M cash; operating cash flow -$64.2M a quarter.Report 2026-09-30
Shares outstanding34,214,683 (2026-11-06); 20,341,589 a year earlier; 190,770,566 three years earlier. 3y figure adjusted for splits (1-for-15 overall).Cover page 2026-11-06
Reverse splits, 3 years1; latest 1-for-15 on 2025-06-09Source 2025-06-09
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 5 424B5 takedowns, 5 at the marketLatest 2026-05-08
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, San Mateo, California, United StatesPCAOB Form AP 2026-04-02
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $2.4M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$9.4M-$55.7M-$71.9M$34.7MNo debt tags$52.2M10-Q 2026-11-13
Q2 2026
2026-06-30
$10.1M-$40.6M-$75.8M$39.3MNo debt tags$54.6M10-Q 2026-08-14
Q1 2026
2026-03-31
$10.9M-$44.9M-$44.3M$149.6MNo debt tags$55.6M10-Q 2026-05-08
Q4 2025
2025-12-31
$21.8M-$36.1M-$65.0M$15.1MNo debt tags$55.2M10-K 2026-03-13
Q3 2025
2025-09-30
$11.8M-$35.5M-$48.8M$41.0MNo debt tags$62.6M10-Q 2026-11-13
Q2 2025
2025-06-30
$11.2M-$41.6M-$45.7M$43.0MNo debt tags$74.9M10-Q 2026-08-14
Q1 2025
2025-03-31
$10.5M-$50.9M-$49.1M$38.9MNo debt tags$87.2M10-Q 2026-05-08
Q4 2024
2024-12-31
$29.2M$7.3M-$46.2M$44.3MNo debt tags$98.4M10-K 2026-03-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-05-08
Latest annual report10-K2026-03-13
Latest quarterly / interim10-Q2026-11-13
Latest current report
CURRENT REPORT
8-K2026-11-13
Latest proxyDEFA14A2026-04-24

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.0%
1 month-1.7%
3 months-50.9%
Year to date-11.8%
1 year-30.9%
From 52-week high-62.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
AMPHAmphastar Pharmaceuticals Inc.$29.17-0.68%$1.2B
AAPGAscentage Pharma Group International American Depository Shares$13.29-9.10%$1.2B
SLNSilence Therapeutics Plc American Depository Share$19.80-0.15%$1.2B
MNKDMannKind Corporation$3.96-4.24%$1.3B
GHRSGH Research PLC$18.75-1.83%$1.3B
MLYSMineralys Therapeutics Inc.$14.53-5.22%$1.3B
OMEROmeros Corporation$16.68-4.63%$1.2B
OPKOPKO Health Inc.$1.62-3.57%$1.2B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier